Evans D, Howard E, Giblin C et al (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet Part A 152(2):327–332

Article  Google Scholar 

Lammert M, Friedman JM, Kluwe L, Mautner VF (2005) Prevalence of neurofibromatosis 1 in german children at elementary school enrollment. Arch Dermatol 141(1):71–74. https://doi.org/10.1001/archderm.141.1.71

Article  PubMed  Google Scholar 

Kallionpaa RA, Uusitalo E, Leppavirta J, Poyhonen M, Peltonen S, Peltonen J (2018) Prevalence of neurofibromatosis type 1 in the finnish population. Genet Med 20(9):1082–1086. https://doi.org/10.1038/gim.2017.215

Article  PubMed  Google Scholar 

Poyhonen M, Kytola S, Leisti J (2000) Epidemiology of neurofibromatosis type 1 (NF1) in northern finland. J Med Genet 37(8):632–636. https://doi.org/10.1136/jmg.37.8.632

Article  CAS  PubMed  PubMed Central  Google Scholar 

Legius E, Messiaen L, Wolkenstein P et al (2021) Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med. https://doi.org/10.1038/s41436-021-01170-5

Article  PubMed  PubMed Central  Google Scholar 

Friedman JM (2002) Neurofibromatosis 1: clinical manifestations and diagnostic criteria. J Child Neurol 17(8):548–554. https://doi.org/10.1177/088307380201700802. discussion 71-2, 646-51

Article  CAS  PubMed  Google Scholar 

Uusitalo E, Rantanen M, Kallionpaa RA et al (2016) Distinctive Cancer Associations in patients with neurofibromatosis type 1. J Clin Oncol 34(17):1978–1986. https://doi.org/10.1200/JCO.2015.65.3576

Article  PubMed  Google Scholar 

Evans DG, O’Hara C, Wilding A et al (2011) Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. Eur J Hum Genet 19(11):1187–1191. https://doi.org/10.1038/ejhg.2011.113

Article  PubMed  PubMed Central  Google Scholar 

Wilding A, Ingham SL, Lalloo F et al (2012) Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet 49(4):264–269. https://doi.org/10.1136/jmedgenet-2011-100562

Article  PubMed  Google Scholar 

Rasmussen SA, Yang Q, Friedman JM (2001) Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 68(5):1110–1118. https://doi.org/10.1086/320121

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uusitalo E, Kallionpaa RA, Kurki S et al (2017) Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors. Br J Cancer 116(2):211–217. https://doi.org/10.1038/bjc.2016.403

Article  CAS  PubMed  Google Scholar 

Suarez-Kelly LP, Yu L, Kline D, Schneider EB, Agnese DM, Carson WE (2019) Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature. Hered Cancer Clin Pract 17:12. https://doi.org/10.1186/s13053-019-0110-z

Article  PubMed  PubMed Central  Google Scholar 

Walters S, Maringe C, Butler J et al (2013) Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000–2007: a population-based study. Br J Cancer 108(5):1195–1208. https://doi.org/10.1038/bjc.2013.6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carton C, Evans DG, Blanco I et al (2023) ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1. eClinicalMedicine 56. https://doi.org/10.1016/j.eclinm.2022.101818

eviQ Cancer Treatments Online (2023) Cancer Institute NSW, viewed 1 March 2023. https://www.eviq.org.au/

Daly MB, Pal T, AlHilli Z et al (2023) Genetic/Familial High-Risk Assessment: breast, ovarian, and pancreatic, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19(1)

Seminog OO, Goldacre MJ (2015) Age-specific risk of breast cancer in women with neurofibromatosis type 1. Br J Cancer 112(9):1546–1548. https://doi.org/10.1038/bjc.2015.78

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharif S, Moran A, Huson SM et al (2007) Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 44(8):481–484. https://doi.org/10.1136/jmg.2007.049346

Article  CAS  PubMed  PubMed Central  Google Scholar 

Evans DGR, Kallionpää RA, Clementi M et al (2020) Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study. Genet Sci 22(2):398–406

CAS  Google Scholar 

Howell SJ, Hockenhull K, Salih Z, Evans DG (2017) Increased risk of breast cancer in neurofibromatosis type 1: current insights. Breast Cancer (Dove Med Press) 9:531–536. https://doi.org/10.2147/BCTT.S111397

Article  PubMed  Google Scholar 

Da Silva AV, Rodrigues FR, Pureza M, Lopes VG, Cunha KS (2015) Breast cancer and neurofibromatosis type 1: a diagnostic challenge in patients with a high number of neurofibromas. BMC Cancer 15:183. https://doi.org/10.1186/s12885-015-1215-z

Article  PubMed  PubMed Central  Google Scholar 

Zhou Y, Pan B, Mao F et al (2012) A hidden breast lump covered by nipple appendices in a patient with von recklinghausen disease: a case report and review of the literature. Clin Breast Cancer 12(1):71–75. https://doi.org/10.1016/j.clbc.2011.07.005

Article  PubMed  Google Scholar 

Sharif S, Ferner R, Birch JM et al (2006) Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol 24(16):2570–2575. https://doi.org/10.1200/JCO.2005.03.8349

Article  PubMed  Google Scholar 

Pijpe A, Andrieu N, Easton DF et al (2012) Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ 345:e5660. https://doi.org/10.1136/bmj.e5660

Article  PubMed  PubMed Central  Google Scholar 

Gokalp G, Hakyemez B, Kizilkaya E, Haholu A (2007) Myxoid neurofibromas of the breast: mammographical, sonographical and MRI appearances. Br J Radiol 80(958):e234–e237. https://doi.org/10.1259/bjr/33539044

Article  CAS  PubMed  Google Scholar 

Thompson S, Kaplan SS, Poppiti RJ Jr, Collado-Mesa F, Rabinovich K (2012) Solitary neurofibroma of the breast. Radiol Case Rep 7(4):462. https://doi.org/10.2484/rcr.v7i4.462

Article  PubMed  Google Scholar 

Maani N, Westergard S, Yang J et al (2019) NF1 patients receiving breast Cancer screening: insights from the Ontario High Risk breast screening program. Cancers (Basel) 11(5). https://doi.org/10.3390/cancers11050707

Wanders JO, Holland K, Veldhuis WB et al (2017) Volumetric breast density affects performance of digital screening mammography. Breast Cancer Res Treat 162(1):95–103. https://doi.org/10.1007/s10549-016-4090-7

Article  PubMed  Google Scholar 

Acciavatti RJ, Lee SH, Reig B et al (2023) Beyond breast density: risk measures for breast Cancer in multiple imaging modalities. Radiology 306(3):e222575. https://doi.org/10.1148/radiol.222575

Article  PubMed  Google Scholar 

Mautner VF, Granstrom S, Leark RA (2015) Impact of ADHD in adults with neurofibromatosis type 1: associated psychological and social problems. J Atten Disord 19(1):35–43. https://doi.org/10.1177/1087054712450749

Article  PubMed  Google Scholar 

Ferner RE, Hughes RA, Weinman J (1996) Intellectual impairment in neurofibromatosis 1. J Neurol Sci 138(1–2): 125 – 33 DOI 10.1016/0022-510x(96)00022 – 6

Crawford HA, Barton B, Wilson MJ et al (2015) The impact of neurofibromatosis type 1 on the Health and Wellbeing of australian adults. J Genet Couns 24(6):931–944. https://doi.org/10.1007/s10897-015-9829-5

Article  PubMed  Google Scholar 

Biglia N, Bounous VE, Martincich L et al (2011) Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast. Eur J Surg Oncol (EJSO) 37(3):199–204

Article  CAS  PubMed  Google Scholar 

Salem DS, Kamal RM, Mansour SM, Salah LA, Wessam R (2013) Breast imaging in the young: the role of magnetic resonance imaging in breast cancer screening, diagnosis and follow-up. J Thorac Dis 5(Suppl 1):S9–S18. https://doi.org/10.3978/j.issn.2072-1439.2013.05.02

Article  PubMed  PubMed Central  Google Scholar 

Lord SJ, Lei W, Craft P et al (2007) A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 43(13):1905–1917. https://doi.org/10.1016/j.ejca.2007.06.007

Article  CAS  PubMed  Google Scholar 

Riedl CC, Luft N, Bernhart C et al (2015) Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol 33(10):1128–1135. https://doi.org/10.1200/JCO.2014.56.8626

Article  PubMed  PubMed Central  Google Scholar 

Checka CM, Chun JE, Schnabel FR, Lee J, Toth H (2012) The relationship of mammographic density and age: implications for breast cancer screening. AJR Am J Roentgenol 198(3):W292–W295. https://doi.org/10.2214/AJR.10.6049

Article  PubMed  Google Scholar 

Kelemen LE, Pankratz VS, Sellers TA et al (2008) Age-specific trends in mammographic density: the Minnesota breast Cancer Family Study. Am J Epidemiol 167(9):1027–1036. https://doi.org/10.1093/aje/kwn063

Article  PubMed  Google Scholar 

Crook A, Kwa R, Ephraums S et al (2021) The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1. Fam Cancer. https://doi.org/10.1007/s10689-021-00259-9

Article  PubMed  PubMed Central  Google Scholar 

Radiology ACo, D’Orsi CJ (2013) ACR BI-RADS atlas: breast imaging reporting and data system; mammography, ultrasound, magnetic resonance imaging, follow-up and outcome monitoring, data dictionary. ACR, American College of Radiology

Mall S, Noakes J, Kossoff M et al (2018) Can digital breast tomosynthesis perform better than standard digital mammography work-up in breast cancer assessment clinic? Eur Radiol 28(12):5182–5194

Article  CAS  PubMed